05:57 AM EDT, 08/20/2026 (MT Newswires) -- Peptonic Medical (PMED.ST) secured a new order from its existing US client for women's intimate self-care during and after menopause, according to a Thursday release. The products will be marketed and sold in the US, Canada, Mexico, and the UK under the client's own brand. The Swedish medical technology company said the new contract is roughly the same size as the initial one of $120,000 obtained in October 2025.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.